06185 康希诺生物
实时 按盘价 升18.360 +0.300 (+1.661%)
最新  |  全年  |  中期
2023/12 - 末期
人民币()
与去年末期
比较
2022/12
人民币()
2021/12
人民币()
2020/12
人民币()
2019/12
人民币()
非流动资产
投资物业0--0000
物业、厂房、设备及其他2,838,342,000-0.708%2,858,592,0001,973,729,000873,375,000575,504,000
租賃土地295,812,000-7.752%320,669,000343,091,00043,998,00032,716,000
无形资产111,841,000-31.226%162,622,00099,790,00036,838,00038,689,000
联营公司及共同控制公司权益18,168,000459.015%3,250,000000
其他非流动资产873,778,000121.973%393,642,000167,733,000373,219,000343,344,000
4,137,941,00010.676%3,738,775,0002,584,343,0001,327,430,000990,253,000
流动资产
存货350,656,000-48.264%677,777,000875,621,000170,512,00016,338,000
现金及银行结存2,046,998,000-39.702%3,394,824,0005,456,873,0004,447,029,000202,450,000
其他流动资产2,783,174,000-23.907%3,657,584,0002,957,350,000803,102,000575,457,000
持作出售资产0--0000
5,180,828,000-32.979%7,730,185,0009,289,844,0005,420,643,000794,245,000
流动负债
其他流动负债2,591,844,000-11.904%2,942,065,0002,874,942,000412,853,000124,295,000
持作出售资产相关负债0--0000
2,591,844,000-11.904%2,942,065,0002,874,942,000412,853,000124,295,000
流动资产净值2,588,984,000-45.929%4,788,120,0006,414,902,0005,007,790,000669,950,000
资产总额减流动负债6,726,925,000-21.109%8,526,895,0008,999,245,0006,335,220,0001,660,203,000
非流动负债
1,439,510,00012.348%1,281,293,000451,361,000264,366,000189,687,000
资本及储备
  股本247,450,0000.000%247,450,000247,450,0006,772,398,0001,792,933,000
  储备5,027,154,000-22.667%6,500,640,0007,747,596,000(701,544,000)(322,417,000)
  其他0--0000
股东资金5,274,604,000-21.836%6,748,090,0007,995,046,0006,070,854,0001,470,516,000
非控股权益12,811,000-97.425%497,512,000552,838,00000
其他0--0000
5,287,415,000-27.026%7,245,602,0008,547,884,0006,070,854,0001,470,516,000
承担及或然负债
承担----551,182,000311,666,000180,527,00026,419,000
或然负债----0000
备注: 实时报价更新时间为25/04/2024 17:14
  港股实时基本市场行情由香港交易所提供; 香港交易所指定免费发放实时基本市场行情的网站。
证券代号
公司名称(中/英/关键字)
行业
 
股东应占溢利/(亏损) ()RMB -1,482,732,000
增长率63.040%
每股盈利/(亏损)RMB -6.010
每股账面资产净值 (¥)RMB 21.316